Non-specific interfaces, membranes, and anionic polyelectrolytes

Non-specific interfaces, membranes, and anionic polyelectrolytes represent a broad category of biological structures and physical environments that serve as sites for drug interaction outside of traditional protein-ligand binding. Biological membranes, primarily lipid bilayers, are essential for cellular compartmentalization and are targeted by various antimicrobial and antifungal agents that disrupt membrane integrity (Source: PubChem, 2024). Anionic polyelectrolytes include highly charged molecules such as DNA, RNA, and glycosaminoglycans like heparin, which interact with cationic drugs through strong electrostatic forces (Source: Schiedel et al., 2020, Chemical Science). Because these targets are defined by their physical properties rather than a unique sequence or fold, drugs acting on them often exhibit broad-spectrum activity. For instance, polymyxins target the lipopolysaccharides in bacterial membranes to induce lysis, while heparin is neutralized by the cationic protein protamine (Source: NIH, StatPearls). However, targeting these non-specific interfaces presents significant challenges in achieving selectivity over host cell membranes. This lack of specificity can lead to safety concerns such as hemolysis or nephrotoxicity. Understanding these interactions is crucial for the development of membrane-active therapeutics and the delivery of nucleic acid-based drugs. Overall, this category highlights the importance of physical chemistry in pharmacology beyond specific receptor-mediated signaling.

Other names

Lipid bilayersAnionic polymersBiological membranesPolyelectrolyte complexesNon-specific binding sites

Drugs targeting these interfaces typically utilize physical mechanisms such as membrane permeabilization, pore formation, or electrostatic neutralization of anionic charges to exert their biological effects (Source: NIH, StatPearls; Nature Reviews Drug Discovery, 2016).